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Bisphenol A (BPA) is a weak estrogenic mono-
mer used to produce plastic polymers such as 
polycarbonate plastics and epoxy resins that 
can be found in toys, water supply pipes, med-
ical tubing, and food container linings. More 
than 6 billion pounds of BPA were manu-
factured worldwide in 2003, making it one 
of the highest production-volume chemicals 
(Burridge 2003). Polymers made from BPA 
can be hydrolyzed in high temperature, acidic, 
and basic conditions, leading to BPA leaching 
into water and food containers and baby feed-
ing bottles (Brede et al. 2003; Factor 1996; 
Nerin et al. 2003; Tan and Mustafa 2003).
The ubiquity of BPA-containing plas-
tics makes human exposure nearly universal 
in developed countries. More than 90% of 
the U.S. population has detectable levels of 
urinary BPA (Calafat et al. 2008). BPA has 
also been detected in the urine and serum of 
pregnant women (Padmanabhan et al. 2008; 
Schonfelder et al. 2002; Wolff et al. 2008; Ye 
et al. 2008) and serum, plasma, and placenta of 
newborn infants (Lee et al. 2008; Schonfelder 
et al. 2002).
Given the role that estrogen and other 
aromatizable androgens play in neuronal 
connectivity, distribution of serotinergic fibers, 
synaptic function, and dendritic length, expo-
sure to endocrine-disrupting compounds such 
as BPA may alter the course of normal neu-
rodevelopment (Palanza et al. 1999). Prenatal 
BPA exposure in rodent studies is associated 
with increased aggression, morphine- and 
methamphetamine-induced hyperlocomotion, 
and memory impairment (Carr et al. 2003; 
Kawai et al. 2003; Miyagawa et al. 2007; 
Narita et al. 2006; Suzuki et al. 2003). Some 
rodent studies suggest that sex modifies the 
effect of prenatal BPA exposure (Adriani et al. 
2003; Carr et al. 2003; Dessi-Fulgheri et al. 
2002; Fujimoto et al. 2006; Kubo et al. 2001), 
whereas others do not (Farabollini et al. 2002; 
Nagao et al. 1999). The direction of the inter-
action between sex and BPA exposure is not 
clear because most of these studies have used 
different BPA doses, routes of exposure, and 
end points (Chapin et al. 2008).
To date, no studies have examined the 
association between prenatal BPA exposure 
and neurodevelopment in children (Chapin 
et al. 2008). Given the near universal exposure 
to BPA among the general U.S. population 
and the association between BPA exposure 
and neurodevelopment and behavior in animal 
studies, even small effects of BPA on childhood 
neurodevelopment could have profound public 
health impacts (Bellinger 2004b; Needleman 
1990).
We used data from the Health Outcomes 
and Measures of the Environment Study 
to examine the association between prena-
tal BPA exposure and behavior in 2-year-old 
children. We also investigated whether sex 
modified the association between prenatal 
BPA exposure and childhood behavior.
Methods
Study sample. Data were collected from 
mothers and their children participating in 
the Health Outcomes and Measures of the 
Environment Study, an ongoing prospective 
birth cohort in the Cincinnati, Ohio (USA), 
metropolitan area designed to examine low-
level environmental toxin exposure and the 
efficacy of injury and lead hazard controls in 
the home (Dietrich et al. 2005). Beginning 
in March 2003, women were identified from 
seven prenatal clinics associated with three hos-
pitals. Eligibility criteria for the study included 
≤ 19 weeks of gestation, age ≥ 18 years, living 
in a house built before 1978, negative HIV sta-
tus, and not taking medications for seizure or 
thyroid disorders. We mailed letters to 5,184 
women who were ≥ 18 years of age and living 
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Ba c k g r o u n d: Prenatal exposure to bisphenol A (BPA) increases offspring aggression and dimin-
ishes differences in sexually dimorphic behaviors in rodents.
oB j e c t i v e: We examined the association between prenatal BPA exposure and behavior in 2-year-
old children.
Me t h o d s : We used data from 249 mothers and their children in Cincinnati, Ohio (USA). 
Maternal urine was collected around 16 and 26 weeks of gestation and at birth. BPA concentrations 
were quantified using high-performance liquid chromatography–isotope-dilution tandem mass spec-
trometry. Child behavior was assessed at 2 years of age using the second edition of the Behavioral 
Assessment System for Children (BASC-2). The association between prenatal BPA concentrations 
and BASC-2 scores was analyzed using linear regression.
re s u l t s: Median BPA concentrations were 1.8 (16 weeks), 1.7 (26 weeks), and 1.3 (birth) ng/mL. 
Mean (± SD) BASC-2 externalizing and internalizing scores were 47.6 ± 7.8 and 44.8 ± 7.0, respec-
tively. After adjustment for confounders, log10-transformed mean prenatal BPA concentrations were 
associated with externalizing scores, but only among females [β = 6.0; 95% confidence interval (CI), 
0.1–12.0]. Compared with 26-week and birth concentrations, BPA concentrations collected around 
16 weeks were more strongly associated with externalizing scores among all children (β = 2.9; 95% 
CI, 0.2–5.7), and this association was stronger in females than in males. Among all children, mea-
surements collected at ≤ 16 weeks showed a stronger association (β = 5.1; 95% CI, 1.5–8.6) with 
externalizing scores than did measurements taken at 17–21 weeks (β = 0.6; 95% CI, –2.9 to 4.1).
co n c l u s i o n s: These results suggest that prenatal BPA exposure may be associated with external-
izing behaviors in 2-year-old children, especially among female children.
key w o r d s : bisphenol A, children, endocrine, epidemiology, neurodevelopment. Environ Health 
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in a house built before 1978. Of the 1,263 eli-
gible women, 468 provided informed consent 
and enrolled in the study.
Maternal urinary BPA concentrations. 
Women provided three spot urine samples 
collected at approximately 16 and 26 weeks 
of gestation and at birth. Sixteen-week urine 
samples were collected when women were met 
by study staff at their prenatal care appoint-
ments; 26-week urine samples were collected 
when women received their glucose toler-
ance test for gestational diabetes screening. 
Women could have had their urine samples 
taken anytime during the screening test. Birth 
urine samples were typically collected before 
or within 24 hr of parturition.
Urine was collected in polyethylene con-
tainers and stored at –20°C until shipped to 
the Centers for Disease Control and Prevention 
(CDC) Environmental Health Laboratories, 
where they were stored at or below –20°C. 
Some urine samples were stored for 4–5 years 
before analysis. Recent work from the CDC 
laboratories suggests that urinary BPA species 
are stable for at least 6 months (Ye et al. 2007) 
and even as long as 30 months (Calafat et al. 
2009) when the urine sample is stored at sub-
freezing temperatures.
The concentration of total (free plus con-
jugated) species of urinary BPA was quantified 
using modified analytical methods previously 
described (Ye et al. 2005a, 2005b). Urine 
samples were treated with β-glucuronidase/
sulfatase to hydrolyze conjugated BPA species. 
After hydrolysis, urine samples were acidi-
fied and then BPA was preconcentrated using 
online solid-phase extraction. BPA concentra-
tions were quantified using high-performance 
liquid chromatography–isotope-dilution tan-
dem mass spectrometry. The limit of detection 
(LOD) was 0.4 µg/L. Concentrations below 
the LOD were given a value of LOD/√2
–
 
for statistical analyses (Hornung and Reed 
1990). Four quality control (QC) samples 
were analyzed in each analytic run. The low-
concentration QC samples (~ 2.8 µg/L) had 
a coefficient of variation (CV) of 6.9–9.2%, 
whereas the high-concentration QC samples 
(~ 9.7 µg/L) had a CV of 3.4–7.6%.
Childhood behavior. We assessed children’s 
behavior at 2 years of age using the second edi-
tion of the Behavioral Assessment System for 
Children (BASC-2) Parent Rating Scale for 
preschoolers (Reynolds and Kamphaus 2002).
The BASC-2 is a 134-item parent-reported 
assessment of a child’s adaptive and problem 
behaviors in community and home settings. 
The preschool version is appropriate for chil-
dren 2–5 years of age and has excellent reli-
ability and validity for assessing adaptive and 
maladaptive behaviors (Ostrander et al. 1998; 
Reynolds and Kamphaus 2002). Composite 
scores are derived by the publisher’s com-
puterized scoring program for externalizing, 
internalizing, and Behavior Symptom Index 
(BSI) scales, each with clinical subscales. 
Scores were normalized to a mean (± SD) of 
50 ± 10 during the national standardization 
of the instrument. On the clinical behavioral 
subscales, scores in the range of 60–69 are 
considered “at risk,” and scores ≥ 70 are con-
sidered clinically significant. Composite scores 
for externalizing behaviors consist of hyper-
activity and aggression scales, and internal-
izing composite scores consist of depression, 
anxiety, and somatization scales. The BSI is a 
composite score that reflects the overall level 
of problem behaviors and consists of scales 
for aggression, hyperactivity, depression, and 
attention. We used the general combined sex-
normalized scores for our analyses. Creatinine-
adjusted prenatal BPA concentrations were not 
qualitatively or statistically different between 
children with and without BASC-2 scores.
The BASC-2 uses the F-index as a mea-
sure of a parent’s tendency to be overly neg-
ative when describing their child. BASC-2 
assessments with F-index scores > 3.0 are to 
be interpreted cautiously; however, in this 
study no BASC-2 assessments at 2 years of 
age had F-index ratings > 3.0.
Confounders. We used directed acy-
clic graphs (DAGs) to examine the role of 
potential confounders in our exposure–disease 
relation (Greenland and Brumback 2002; 
Greenland et al. 1999). Simulation studies 
have shown that DAGs are a better method to 
assess the role of confounding variables than 
are change in estimate and significance test-
ing approaches (Greenland 2008). Because 
little is known about factors associated with 
BPA exposures, we adjusted for many of 
the same confounders that are thought to 
confound other environmental toxin–neu-
rodevelopment relations (Bellinger 2004a), 
including maternal and child demographic 
factors such as maternal age (< 25, 25–34, and 
≥ 35 years), race (white and nonwhite), educa-
tion (< 12, 12, and > 12 years), marital status 
(married and nonmarried), annual household 
income (< $40,000, $40,000 to < $80,000, 
≥ $80,000), and child sex. Maternal depression 
during pregnancy was measured at 20 weeks of 
gestation with the second edition of the Beck 
Depression Inventory (BDI-II) (Beck et al. 
1996). Women were classified as minimally 
or mildly depressed (BDI-II score < 20) and 
moderately or severely depressed (BDI-II score 
≥ 20). Caregiving environment was measured 
by administering the Home Observation for 
Measurement of the Environment (HOME) 
Inventory during a 12-month home visit 
(Caldwell and Bradley 2003). HOME scores 
were categorized as < 35, 35–39, and ≥ 40 
based on the distribution of the scores.
Statistical analysis. Demographic charac-
teristics of the 389 mothers and their singleton 
children were compared with the 249 dyads 
with complete urinary BPA and BASC-2 data. 
Descriptive statistics of BPA concentrations 
at each time point were calculated along with 
the proportion of measurements below the 
LOD. We also calculated the Pearson cor-
relation coefficient between the nonadjusted 
and creatinine-adjusted BPA concentrations at 
each time point.
We examined the shape of the associa-
tion between maternal BPA concentration and 
children’s behavior using graphical and locally 
weighted scatterplot smoothing (LOESS) anal-
ysis. LOESS uses locally weighted polynomials 
to fit subsets of data using ordinary least squares 
regression, giving more weight to points closer 
to the point being estimated, and less weight to 
points farther away (Cleveland 1979).
We started our analyses by examining 
the association between the mean prenatal 
BPA concentration (i.e., the mean of 16- and 
26-week and birth BPA concentrations) and 
externalizing, internalizing, and BSI scores 
using multivariable linear regression. We used 
continuous log10-transformed mean BPA con-
centrations and quartiles of the mean BPA 
concentration in separate models. Coefficients 
from the continuous models represent the 
mean change in BASC-2 scores for a 10-fold 
increase in BPA concentrations. Adjusted 
mean scores for each quartile were calcu-
lated, as well as the difference between the 
first quartile mean score and the other three 
quartiles’ mean score.
Next, we analyzed the association between 
each individual BPA measurement and exter-
nalizing, internalizing, and BSI scores to exam-
ine whether the association was dependent on 
the timing of exposure. We constructed mod-
els using each log10-transformed BPA concen-
tration and quartiles of BPA concentration as 
the independent variable.
Finally, we examined the association 
between early prenatal BPA exposure and 
BASC-2 scores, by looking for differences in 
the association between BPA concentrations 
and BASC-2 scores based on the timing of the 
16-week urine measurement. Each individual 
woman had only one urine sample taken at 
approximately 16 weeks of gestation. We esti-
mated the gestational week of the 16-week 
measurement using women’s reported last 
menstrual period (LMP). We dichotomized 
the timing of the 16-week urine measure-
ment at the median value of 16 weeks. We 
included a product interaction term between 
the log10-transformed BPA concentration and 
the dichotomous measurement time variable. 
This allowed us to estimate the association 
between BPA concentrations and BASC-2 
scores separately for women with measure-
ments ≤ 16 weeks of gestation and > 16 weeks 
of gestation.
Based on previous animal literature sug-
gesting that BPA may be associated with Prenatal bisphenol A exposure and childhood behavior
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disruptions in sexually dimorphic behaviors, 
we estimated sex-specific associations between 
BPA concentrations and BASC-2 scores by 
including a product interaction term between 
the BPA concentration and child sex variables. 
Male- and female-specific slope coefficients 
were computed from regression models using 
continuous BPA concentration, whereas sex-
specific means and differences were calculated 
from models using creatinine-adjusted BPA 
concentration quartiles. We assessed for the 
presence of sex modification by examining the 
p-value for the interaction term between BPA 
concentration and sex. We considered p-values 
< 0.10 to be indicative of effect measure modi-
fication (Rothman and Greenland 1998).
We used urinary creatinine concentra-
tions to control for urine dilution in all of our 
analyses. In models using continuous mean 
prenatal BPA concentrations, each individ-
ual BPA concentration was divided by the 
respective urinary creatinine concentration 
before taking the mean of the measurements. 
In models using individual BPA concentra-
tions, we included the log10-transformed 
urinary creatinine value from the respec-
tive measurement in our models. In analyses 
involving percentiles, we created percentiles 
from the distribution of creatinine-adjusted 
BPA concentrations. We excluded 10, 20, 
and 15 women with urinary creatinine values 
< 20 mg/dL at the 16-week, 26-week, and 
birth measurement, respectively, to reduce 
the influence of values from very dilute urine 
(Wolff et al. 2008).
Secondary analyses. Several sets of sec-
ondary analyses were conducted. First, we 
sought to determine if mean and time-specific 
prenatal (16 and 26 weeks of gestation and 
birth) serum cotinine or blood lead levels con-
founded the association between BPA con-
centrations and BASC-2 scores. Concurrent 
log10-  transformed serum cotinine or blood lead 
levels were entered into respective log10-trans-
formed continuous BPA models (i.e., 16-week 
cotinine included in 16-week BPA model). 
We also ran models that included both serum 
cotinine and blood lead levels. Second, we 
conducted an additional analysis that included 
Full Scale maternal IQ (Wechsler Abbreviated 
Scales of Intelligence) as a continuous vari-
able in our model (Wechsler 1999). We also 
conducted additional analyses that included 
women with urinary creatinine concentrations 
< 20 mg/dL to see whether this restriction 
changed our estimates. All analyses were con-
ducted with SAS version 9.2 (SAS Institute 
Inc., Cary, NC, USA).
Ethical considerations. The institutional 
review boards (IRBs) of the University of 
North Carolina–Chapel Hill, Cincinnati 
Children’s Hospital Medical Center, and 
CDC approved this study. The University 
of Cincinnati College of Medicine IRB 
was involved in the oversight of this study 
throughout all stages of planning and imple-
mentation. All mothers provided written 
informed consent for themselves and their 
children before enrollment in the study.
Results
Of the 468 women who enrolled in our study, 
67 dropped out before delivery. We excluded 
nine sets of twins, and three stillborn children. 
Among the 389 women with singleton live 
births, all three urine samples were collected 
from 332 (85.3%) women. BASC-2 scores 
were available for 249 (64.0%) of the children 
whose mothers had all three urinary BPA mea-
surements. Women from dyads with complete 
BPA and BASC-2 data were more likely to be 
white, better educated, wealthier, married, and 
25–34 years of age than women in the original 
sample (Table 1). Among the 249 children 
born to women with all three prenatal BPA 
concentrations, the mean (± SD) externalizing, 
internalizing, and BSI scores were 47.6 ± 7.8 
(range, 30–84), 44.8 ± 7.0 (range, 31–68), 
and 50.5 ± 6.8 (range, 34–74), respectively.
Almost all (n = 247, 99.2%) women had at 
least one urine sample with a detectable urinary 
BPA concentration (Table 2; 16 weeks, 89.2%; 
26 weeks, 89.6%; birth, 87.1%). One woman’s 
26-week urine BPA concentration was 3 orders 
of magnitude higher than the median 26-week 
concentration. Excluding this woman’s results 
did not substantially alter our effect estimates. 
Creatinine-adjusted BPA concentration dis-
tributions were very similar across pregnancy 
and at birth. Log10-transformed BPA concen-
trations were modestly correlated at 16 and 
26 weeks (Pearson r = 0.30), 16 weeks and 
birth (Pearson r = 0.26), and 26 weeks and 
birth (Pearson r = 0.28). We found little cor-
relation between log10-transformed creatinine-
  adjusted BPA concentrations at 16 and 
26 weeks (Pearson r = 0.11), 16 weeks and 
birth (Pearson r = 0.11), and 26 weeks and 
birth (Pearson r = 0.08)
LOESS analysis revealed linear associa-
tions between mean and individual urinary 
BPA concentrations and BASC-2 scores. 
We found no association between mean 
prenatal BPA concentrations and external-
izing, internalizing, or BSI scores for the 
entire sample. In sex-stratified analyses, we 
observed a positive association among females 
between log10-transformed mean prenatal 
Table 1. Demographic, maternal, and household characteristics of all mother–child dyads and those with 
all urine measurements and 2-year BASC-2 data in the HOME study [no. (%)]. 
Variable
All women and children 
(n = 389)
Women and children with all urine 
and behavior measurements (n = 249)
Child sex
Female 208 (53.5) 131 (52.6)
Male 181 (46.5) 118 (47.4)
Missing 0 0
Maternal race
White 237 (61.7) 180 (72.3)
Nonwhite 147 (38.3) 69 (27.7)
Missing 5 0
Maternal education (years)
< 12 41 (10.7) 16 (6.4)
12 54 (13.8) 22 (8.8)
> 12 289 (74.5) 211 (84.7)
Missing 5 0
Annual household income category
< $40,000 153 (40.7) 72 (29.6)
$40,000 to < $80,000 120 (31.9) 94 (38.7)
≥ $80,000 103 (27.4) 77 (31.7)
Missing 13 6
Maternal marital status
Married 249 (64.8) 188 (75.5)
Single 135 (35.2) 61 (24.5)
Missing 5 0
Maternal age category (years)
< 25 96 (24.7) 43 (17.3)
25–34 231 (59.4) 168 (67.5)
≥ 35 62 (15.9) 38 (15.3)
Missing 0 0
HOME score category (12 months)
< 35 51 (15.3) 29 (11.8)
35–39 64 (19.2) 39 (15.8)
≥ 40 219 (65.6) 178 (72.4)
Missing 55 3
Maternal BDI-II at 20 weeks
Minimal or mild depression (0–19) 345 (92.0) 230 (93.1)
Moderate or severe depression (≥ 20) 30 (8.0) 17 (6.9)
Missing 14 2Braun et al.
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BPA concentrations and externalizing [β = 
6.0; 95% confidence interval (CI), 0.1–12.0] 
and BSI scores (β = 5.5; 95% CI, 0.3–10.7), 
but not among males (p-value for interaction 
< 0.05; Table 3).
Covariate and creatinine-adjusted log10-
transformed 16-week BPA concentrations 
were positively associated with externalizing 
scores (Table 4; β = 2.9; 95% CI, 0.2–5.7). 
The association between continuous 16-week 
BPA concentrations and externalizing scores 
was stronger among females (β = 4.8; 95% 
CI, 1.3–8.3) than for males (β = 1.1; 95% CI, 
–2.4 to 4.6). Sex also modified the association 
between 16-week BPA maternal concentrations 
Table 2. Descriptive statistics of 16-week, 26-week, and birth urinary BPA concentrations among mothers enrolled in the HOME study. 
Percentile
n ≥ LOD (%) Minimuma 5th  25th  50th 75th  95th Maximum
No creatinine adjustment (µg/L)
All children (n = 249)
16 weeks 222 (89.2) < LOD < LOD 0.8 1.8 3.2 9.7 37.3
26 weeks 223 (89.6) < LOD < LOD 0.8 1.7 3.0 9.8 1,250
Birth 217 (87.1) < LOD < LOD 0.7 1.3 2.5 6.6 48.7
Mean  NA < LOD 0.5 1.1 2.0 3.3 8.2 421
Males (n = 118)
16 weeks 104 (88.1) < LOD < LOD 0.8 1.8 3.0 9.6 19.5
26 weeks 109 (92.4) < LOD < LOD 0.8 1.7 3.1 12.5 1,250
Birth 103 (87.3) < LOD < LOD 0.7 1.4 2.5 6.8 48.7
Mean  NA < LOD 0.5 1.1 1.9 3.2 8.5 421
Females (n = 131)
16 weeks 118 (90.1) < LOD < LOD 0.9 1.9 3.4 10.3 37.3
26 weeks 114 (87.0) < LOD < LOD 0.8 1.5 3.0 9.0 41.3
Birth 114 (87.0) < LOD < LOD 0.7 1.2 2.5 6.5 12.0
Mean  NA < LOD 0.5 1.1 2.0 3.3 7.6 17.7
Creatinine adjusted (µg/g)
All children (n = 249)
16 weeks 222 (89.2) < LOD < LOD 1.1 1.6 3.0 22.2 34.8
26 weeks 223 (89.6) < LOD < LOD 1.3 2.0 3.1 8.0 583
Birth 217 (87.1) < LOD < LOD 1.2 1.9 2.9 9.2 27.3
Mean NA < LOD 1.0 1.6 2.2 3.4 8.0 196
Males (n = 118)
16 weeks 104 (88.1) < LOD < LOD 1.0 1.5 3.0 9.3 19.4
26 weeks 109 (92.4) < LOD < LOD 1.3 2.1 3.1 10.0 583.0
Birth 103 (87.3) < LOD < LOD 1.2 1.7 2.6 9.6 27.3
Mean  NA < LOD 0.9 1.6 2.1 3.3 7.8 196
Females (n = 131)
16 weeks 118 (90.1) < LOD < LOD 1.1 1.8 3.0 10.7 34.8
26 weeks 114 (87.0) < LOD < LOD 1.3 2.0 3.1 6.2 32.8
Birth 114 (87.0) < LOD < LOD 1.2 2.0 3.1 9.2 15.8
Mean  NA < LOD 1.1 1.6 2.3 3.4 8.0 13.9
NA, not applicable.
aLOD = 0.4 µg/L; 5th percentile values are 0.28 (LOD/√– 2). 
Table 3. Adjusted associations between mean prenatal creatinine-adjusted BPA concentration and externalizing, internalizing, and BSI BASC-2 scores among 
2-year-old children in the HOME study.















First quartile (0–1.52 µg/g) 46.5 ± 1.1 Reference 48.4 ± 1.5 Reference 44.5 ± 1.5 Reference
Second quartile (1.53–2.10 µg/g) 46.6 ± 1.1 0.1 (–3.0 to 3.2) 49.4 ± 1.4 1.1 (–3.1 to 5.2) 43.2 ± 1.7 –1.4 (–5.9 to 3.1)
Third quartile (2.11–3.31 µg/g) 48.7 ± 1.1 2.2 (–0.9 to 5.3) 49.7 ± 1.7 1.3 (–3.2 to 5.9) 47.7 ± 1.4 3.1 (–1.0 to 7.3)
Fourth quartile (> 3.31 µg/g) 48.0 ± 1.1 1.5 (–1.6 to 4.6) 47.0 ± 1.5 –1.4 (–5.7 to 2.9) 48.9 ± 1.5 4.4 (0.1 to 8.6)*
Log10-transformed coefficient 1.0 (–2.7 to 4.7) –1.9 (–6.4 to 2.7) 6.0 (0.1 to 12.0)**
Internalizing score
First quartile (0–1.52 µg/g) 44.1 ± 1.0 Reference 43.3 ± 1.4 Reference 44.9 ± 1.4 Reference
Second quartile (1.53–2.10 µg/g) 44.2 ± 1.0 0.1 (–2.7 to 2.8) 45.1 ± 1.3 1.8 (–1.9 to 5.6) 42.9 ± 1.5 –2.0 (–6.1 to 2.1)
Third quartile (2.11–3.31 µg/g) 44.5 ± 1.0 0.4 (–2.4 to 3.1) 45.4 ± 1.5 2.2 (–2.0 to 6.3) 43.9 ± 1.2 –0.9 (–4.7 to 2.8)
Fourth quartile (> 3.31 µg/g) 44.4 ± 1.0 0.3 (–2.5 to 3.1) 42.3 ± 1.4 –0.9 (–4.8 to 3.0) 46.5 ± 1.4 1.6 (–2.3 to 5.5)
Log10-transformed coefficient –0.4 (–3.7 to 2.9) –2.1 (–6.2 to 2.0) 2.8 (–2.7 to 8.2)
BSI score
First quartile (0–1.52 µg/g) 50.5 ± 1.0 Reference 52.5 ± 1.3 Reference 48.3 ± 1.4 Reference
Second quartile (1.53–2.10 µg/g) 49.5 ± 1.0 –1.0 (–3.7 to 1.7) 51.8 ± 1.2 –0.7 (–4.4 to 3.0) 46.8 ± 1.5 –1.5 (–5.5 to 2.4)
Third quartile (2.11–3.31 µg/g) 50.9 ± 1.0 0.4 (–2.3 to 3.1) 51.9 ± 1.5 –0.6 (–4.6 to 3.4) 49.8 ± 1.2 1.5 (–2.1 to 5.1)
Fourth quartile (> 3.31 µg/g) 50.5 ± 1.0 0.0 (–2.7 to 2.7) 49.3 ± 1.4 –3.2 (–7.0 to 0.6) 51.5 ± 1.3 3.2 (–0.6 to 6.9)**
Log10-transformed coefficient 0.0 (–3.3 to 3.2) –3.1 (–7.1 to 0.8) 5.5 (0.3 to 10.7)**
aAdjusted for maternal age (< 25, 25–34, and ≥ 35 years), child sex, race (white and nonwhite), maternal education (< 12 years, 12 years, > 12 years), household income (< $40,000, 
$40,000 to < $80,000, ≥ $80,000), HOME score (< 35, 35 to < 40, and ≥ 40), marital status (married vs. unmarried), and maternal depression during pregnancy (minimal/mild vs. moderate/
severe). bAdjusted for maternal age (< 25, 25–34, and ≥ 35 years), race (white and nonwhite), maternal education (< 12 years, 12 years, > 12 years), household income (< $40,000, $40,000 
to < $80,000, ≥ $80,000), HOME score (< 35, 35 to < 40, and ≥ 40), marital status (married vs. unmarried), and maternal depression during pregnancy (minimal/mild vs. moderate/severe).
*p-Value < 0.10 for the interaction term between BPA concentration and child sex. **p-Value < 0.05 for the interaction term between BPA concentration and child sex.Prenatal bisphenol A exposure and childhood behavior
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Table 4. Adjusted associations between individual creatinine-adjusted BPA concentrations and BASC-2 externalizing, internalizing, and BSI scores among 
2-year-old children participating in the HOME study.














16-week BPA concentrations n = 229 n = 113 n = 116
Externalizing scores
First quartile (0–1.09 µg/g) 45.2 (1.1) Reference 47.7 (1.4) Reference 42.2 (1.5) Reference
Second quartile (1.10–1.62 µg/g) 47.2 (1.1) 2.1 (–0.7 to 4.8) 48.9 (1.3) 1.2 (–2.4 to 4.8) 45.5 (1.6) 3.2 (–0.9 to 7.4)
Third quartile (1.63–2.88 µg/g) 48.1 (1.1) 2.9 (0.2 to 5.7) 47.7 (1.7) 0.0 (–4.1 to 4.2) 47.8 (1.3) 5.5 (1.8 to 9.3)*
Fourth quartile (> 2.88 µg/g) 49.0 (1.0) 3.9 (1.1 to 6.6) 49.1 (1.4) 1.4 (–2.3 to 5.2) 49.0 (1.4) 6.7 (2.7 to 10.7)*
Log10-transformed coefficientc 2.9 (0.2 to 5.7) 1.1 (–2.4 to 4.6) 4.8 (1.3 to 8.3)*
Internalizing scores
First quartile (0–1.09 µg/g) 44.6 (1.0) Reference 44.6 (1.3) Reference 44.4 (1.4) Reference
Second quartile (1.10–1.62 µg/g) 43.3 (1.1) –1.2 (–3.8 to 1.3) 42.7 (1.2) –1.9 (–5.3 to 1.4) 44.1 (1.5) –0.3 (–4.2 to 3.5)
Third quartile (1.63–2.88 µg/g) 44.0 (1.0) –0.5 (–3.1 to 2.0) 44.2 (1.6) –0.4 (–4.3 to 3.4) 44.1 (1.2) –0.3 (–3.8 to 3.2)
Fourth quartile (> 2.88 µg/g) 45.8 (1.0) 1.2 (–1.3 to 3.8) 45.0 (1.3) 0.3 (–3.2 to 3.8) 46.6 (1.3) 2.3 (–1.5 to 6.0)
Log10-transformed coefficientc 1.1 (–1.4 to 3.6) 0.0 (–3.2 to 3.3) 2.3 (–1.0 to 5.5)
BSI scores
First quartile (0–1.09 µg/g) 49.0 (1.0) Reference 51.6 (1.2) Reference 45.8 (1.4) Reference
Second quartile (1.10–1.62 µg/g) 49.7 (1.0) 0.8 (–1.7 to 3.2) 51.1 (1.2) –0.5 (–3.7 to 2.7) 48.3 (1.4) 2.5 (–1.2 to 6.1)
Third quartile (1.63–2.88 µg/g) 50.9 (1.0) 1.9 (–0.5 to 4.4) 50.9 (1.5) –0.7 (–4.4 to 3.0) 50.4 (1.2) 4.6 (1.3 to 7.9)**
Fourth quartile (> 2.88 µg/g) 51.0 (0.9) 2.1 (–0.4 to 4.5) 50.3 (1.3) –1.3 (–4.7 to 2.0) 51.8 (1.2) 6.0 (2.4 to 9.5)**
Log10-transformed coefficientc 1.4 (–1.0 to 3.9) –0.6 (–3.7 to 2.5) 3.5 (0.4 to 6.6)**
26-week BPA concentrations n = 218 n = 106 n = 112
Externalizing scores
First quartile (0–1.24 µg/g) 47.5 (1.2) Reference 48.8 (1.6) Reference 46.3 (1.6) Reference
Second quartile (1.25–1.97 µg/g) 48.1 (1.1) 0.5 (–2.4 to 3.5) 49.4 (1.6) 0.6 (–3.6 to 4.8) 46.8 (1.6) 0.4 (–3.7 to 4.6)
Third quartile (1.98–3.07 µg/g) 45.9 (1.2) –1.6 (–4.6 to 1.3) 47.3 (1.5) –1.6 (–5.8 to 2.6) 44.7 (1.6) –1.7 (–5.8 to 2.5)
Fourth quartile (> 3.07 µg/g) 47.3 (1.1) –0.2 (–3.2 to 2.8) 48.1 (1.6) –0.7 (–5.0 to 3.6) 46.6 (1.5) 0.2 (–3.9 to 4.3)
Log10-transformed coefficientc –1.0 (–3.9 to 1.9) –1.4 (–4.8 to 2.0) –0.4 (–4.5 to 3.8)
Internalizing scores
First quartile (0–1.24 µg/gm) 45.3 (1.1) Reference 44.3 (1.4) Reference 46.2 (1.4) Reference
Second quartile (1.25–1.97 µg/g) 43.6 (1.0) –1.7 (–4.4 to 1.0) 42.7 (1.4) –1.6 (–5.5 to 2.2) 44.3 (1.4) –1.8 (–5.6 to 1.9)
Third quartile (1.98–3.07 µg/g) 44.5 (1.0) –0.8 (–3.5 to 1.9) 45.1 (1.4) 0.8 (–2.9 to 4.6) 43.8 (1.4) –2.4 (–6.2 to 1.3)
Fourth quartile (> 3.07 µg/g) 44.0 (1.0) –1.3 (–4.0 to 1.4) 43.7 (1.4) –0.6 (–4.5 to 3.2) 44.2 (1.3) –2.0 (–5.7 to 1.7)
Log10-transformed coefficientc –2.0 (–4.6 to 0.7) –1.7 (–4.7 to 1.4) –2.5 (–6.2 to 1.2)
BSI scores
First quartile (0–1.24 µg/g) 51.3 (1.0) Reference 51.7 (1.4) Reference 51.0 (1.4) Reference
Second quartile (1.25–1.97 µg/g) 50.6 (1.0) –0.7 (–3.3 to 1.9) 51.5 (1.4) –0.1 (–3.8 to 3.6) 49.6 (1.4) –1.3 (–5.0 to 2.3)
Third quartile (1.98–3.07 µg/g) 48.6 (1.0) –2.6 (–5.2 to 0.0) 50.4 (1.3) –1.3 (–4.9 to 2.4) 47.0 (1.4) –4.0 (–7.6 to –0.3)
Fourth quartile (> 3.07 µg/g) 49.7 (1.0) –1.6 (–4.2 to 1.0) 51.1 (1.4) –0.5 (–4.3 to 3.2) 48.5 (1.3) –2.5 (–6.1 to 1.1)
Log10-transformed coefficientc –2.2 (–4.7 to 0.4) –1.9 (–4.9 to 1.1) –2.6 (–6.3 to 1.0)
Birth BPA concentrations n = 224 n = 112 n = 112
Externalizing scores
First quartile (0–1.16 µg/g) 46.1 (1.1) Reference 47.3 (1.5) Reference 45.0 (1.5) Reference
Second quartile (1.17–1.80 µg/g) 48.2 (1.2) 2.1 (–0.8 to 5.0) 49.9 (1.5) 2.5 (–1.4 to 6.5) 46.7 (1.7) 1.6 (–2.6 to 5.8)
Third quartile (1.81–2.96 µg/g) 48.2 (1.1) 2.1 (–0.7 to 4.9) 49.7 (1.4) 2.4 (–1.6 to 6.3) 46.8 (1.6) 1.8 (–2.3 to 5.9)
Fourth quartile (> 2.96 µg/g) 48.1 (1.1) 2.0 (–0.8 to 4.9) 48.3 (1.6) 0.9 (–3.2 to 5.1) 47.9 (1.4) 2.8 (–1.1 to 6.8)
Log10-transformed coefficientc 1.8 (–1.2 to 4.8) 1.6 (–2.3 to 5.4) 2.1 (–2.0 to 6.2)
Internalizing scores
First quartile (0–1.16 µg/g) 43.2 (1.0) Reference 41.2 (1.4) Reference 45.1 (1.4) Reference
Second quartile (1.17–1.80 µg/g) 46.2 (1.1) 2.9 (0.2 to 5.6) 46.9 (1.3) 5.6 (2.0 to 9.2) 45.1 (1.5) 0.0 (–3.8 to 3.8)
Third quartile (1.81–2.96 µg/g) 45.5 (1.0) 2.3 (–0.3 to 4.9) 46.7 (1.3) 5.4 (1.8 to 9.1) 44.0 (1.4) –1.1 (–4.8 to 2.7)
Fourth quartile (> 2.96 µg/g) 44.4 (1.0) 1.1 (–1.5 to 3.8) 42.7 (1.4) 1.3 (–2.4 to 5.2) 45.7 (1.3) 0.6 (–3.0 to 4.2)
Log10-transformed coefficientc 0.7 (–2.1 to 3.5) 0.8 (–2.8 to 4.4) 0.5 (–3.3 to 4.3)
BSI scores
First quartile (0–1.16 µg/g) 48.8 (1.0) Reference 48.9 (1.3) Reference 48.7 (1.3) Reference
Second quartile (1.17–1.80 µg/g) 51.7 (1.1) 2.9 (0.3 to 5.5) 53.9 (1.3) 5.0 (1.5 to 8.5) 49.2 (1.5) 0.5 (–3.2 to 4.3)*
Third quartile (1.81–2.96 µg/g) 50.9 (1.0) 2.2 (–0.4 to 4.7) 52.5 (1.3) 3.7 (0.1 to 7.2) 49.3 (1.4) 0.6 (–3.1 to 4.2)
Fourth quartile (> 2.96 µg/g) 50.8 (1.0) 2.1 (–0.5 to 4.6) 50.4 (1.4) 1.5 (–2.2 to 5.2) 51.0 (1.3) 2.3 (–1.2 to 5.8)
Log10-transformed coefficientc 1.4 (–1.3 to 4.1) 0.9 (–2.7 to 4.6) 1.8 (–1.7 to 5.2)
aAdjusted for maternal age (< 25, 25–34, and ≥ 35 years), child sex, race (white and nonwhite), maternal education (< 12 years, 12 years, > 12 years), household income (< $40,000, 
$40,000 to < $80,000, ≥ $80,000), HOME score (< 35, 35 to < 40. and ≥ 40), marital status (married vs. unmarried), and maternal depression during pregnancy (minimal/mild vs. moderate/
severe). bAdjusted for maternal age (< 25, 25–34, and ≥ 35 years), race (white and nonwhite), maternal education (< 12 years, 12 years, > 12 years), household income (< $40,000, $40,000 
to < $80,000, ≥ $80,000), HOME score (< 35, 35 to < 40, and ≥ 40), marital status (married vs. unmarried), and maternal depression during pregnancy (minimal/mild vs. moderate/severe). 
cAdjusted for log10-transformed creatinine concentration, maternal age (< 25, 25–34, and ≥ 35 years), race (white and nonwhite), maternal education (< 12 years, 12 years, > 12 years), 
household income (< $40,000, $40,000 to < $80,000, ≥ $80,000), HOME score (< 35, 35 to < 40, and ≥ 40), marital status (married vs. unmarried), and maternal depression during pregnancy 
(minimal/mild vs. moderate/severe). *p-Value < 0.10 for the interaction term between BPA concentration and child sex. **p-Value < 0.05 for the interaction term between BPA concen-
tration and child sex.Braun et al.
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and children’s BSI scores. Maternal BPA con-
centrations at 26 weeks were not associated 
with children’s externalizing behaviors. We 
found a modest inverse association between 
maternal 26-week BPA concentration and chil-
dren’s internalizing and BSI scores (β = –2.2; 
95% CI, –4.6 to 0.7).
Children born from women in the top 
three quartiles of birth BPA concentrations 
had mean externalizing scores approximately 
2 points higher than those of children from 
women in the lowest quartile. Males born 
from women in the second and third quartiles 
of BPA concentration had higher mean inter-
nalizing and BSI scores compared with males 
born to women in the first quartile.
Mean externalizing scores increased across 
quartiles of maternal creatinine-adjusted 
16-week BPA quartile among female chil-
dren, whereas externalizing scores did not 
differ among males (Figure 1). Externalizing 
scores among females in the third and fourth 
quartiles were comparable to mean external-
izing scores for males.
The timing of the 16-week urine measure-
ment modified the association between BPA 
concentrations and externalizing scores. A total 
of 242 women had LMP-based estimates of the 
16-week measurement. Among these women, 
134 (55.4%) had their urine measurements 
taken at ≤ 16 weeks of gestation (minimum, 
11.2 weeks) and 108 (44.6%) had their mea-
surements taken at > 16 weeks (maximum, 21.4 
weeks). Confounder-adjusted log10-transformed 
BPA concentrations taken at ≤ 16 weeks of ges-
tation were positively associated (β = 5.1; 95% 
CI, 1.5–8.6) with externalizing scores, whereas 
those taken at > 16 weeks of gestation were not 
(β = 0.6; 95% CI, –2.9 to 4.1). The positive 
association between BPA concentrations and 
externalizing behaviors was stronger in females 
(β = 7.0; 95% CI, 3.0–11.0; n = 70) than in 
males (β = 3.0; 95% CI, –1.0 to 7.0; n = 64) 
among mothers whose urine samples were taken 
at ≤ 16 weeks of gestation (p-value for BPA 
× sex interaction term < 0.10). We found no 
qualitative or statistical differences in the mean 
log10-transformed creatinine-adjusted BPA con-
centrations taken at ≤ 16 weeks and > 16 weeks. 
The proportion of males and females was not 
qualitatively or statistically different by the tim-
ing of the 16-week measurement.
Secondary analyses. In secondary analyses, 
the inclusion of maternal blood lead levels, 
maternal serum cotinine levels, or both did 
not substantially alter our results. The inclu-
sion of maternal IQ did not substantially alter 
any of our findings and was not associated 
with BASC-2 scores. Including women with 
urinary creatinine values < 20 mg/dL did not 
substantially change the estimates in any of our 
analyses. Our results were unchanged when we 
conducted analyses that included women with 
one or two missing BPA measurements.
Discussion
This is the first study to examine the association 
between prenatal BPA exposure and childhood 
behavior. We did not observe an association 
between mean urinary BPA concentrations and 
behavior scores among all children. However, 
we report an association between mean prenatal 
BPA concentrations and externalizing scores in 
females. Further examination revealed that the 
association between prenatal BPA concentra-
tions and externalizing behaviors in 2-year-old 
girls was driven by maternal urine BPA concen-
trations measured at 16 weeks of gestation. The 
association between early BPA concentrations 
and externalizing scores was strongest among 
women with urine measurements taken at ≤ 16 
weeks of gestation. The interaction between sex 
and 16-week BPA concentrations persisted in 
samples taken at ≤ 16 weeks of gestation.
Consistent with our findings, some animal 
studies have shown that prenatal BPA expo-
sure is associated with increased aggression 
(Kawai et al. 2003), changes in the dopamin-
ergic system in the limbic forebrain (Narita 
et al. 2006; Suzuki et al. 2003), and other neu-
robehavioral changes (Carr et al. 2003; Kawai 
et al. 2003; Miyagawa et al. 2007; Narita et al. 
2006; Suzuki et al. 2003). To our knowledge, 
only one rodent study has examined for time-
sensitive periods of BPA exposure. Narita et al. 
(2007) reported that BPA exposure during 
organogenesis and breast-feeding caused mor-
phine-induced hyperlocomotion, preference 
for drug-paired place, and up-regulation of 
dopamine receptor function, whereas exposure 
at other gestational time periods did not. 
We observed an inverted U-shaped asso-
ciation between maternal urinary BPA con-
centrations and internalizing behaviors among 
male children in our sample. Others have 
written extensively about the possibility of a 
nonlinear dose–response curve between envi-
ronmental estrogens and various end points 
(Welshons et al. 2003).
Our results suggest that child sex may 
modify the association between prenatal 
BPA exposure and externalizing behaviors. 
Interactions between child sex and prenatal 
exposure to neurodevelopmental toxicants have 
been observed in some epidemiologic stud-
ies (Bellinger et al. 1990; Engel et al. 2009; 
Pocock et al. 1987; Ris et al. 2004; Vreugenhil 
et al. 2002); however, sex-specific effect meas-
ure modification is usually not reported in 
epidemiologic studies. Results from rodent 
studies have reported that sex modifies the 
effect of prenatal BPA exposure (Adriani et al. 
2003; Dessi-Fulgheri et al. 2002; Fujimoto 
et al. 2006; Kubo et al. 2001) and that prena-
tal BPA exposure may abolish or reverse differ-
ences in sexually dimorphic behaviors (Palanza 
et al. 2008). However, it is difficult to label 
effects as feminizing or masculinizing without 
knowing whether these end points are sexually 
dimorphic (Li et al. 2008).
Two issues must be considered when 
comparing the results of our study to those of 
rodent studies. First, the route of exposure in 
animal studies has included oral, subcutane-
ous, and direct injection at target organs (Li 
et al. 2008), whereas humans are exposed pre-
dominantly through the oral route (Chapin 
et al. 2008). Second, animal studies have used 
doses spanning several orders of magnitude, 
many of which are not relevant to human 
exposure (Li et al. 2008).
Prenatal urinary BPA concentrations 
among women in this study were similar to 
those from women of childbearing age from a 
nationally representative U.S. sample (Calafat 
et al. 2008), from a previous study examin-
ing the association between BPA exposure 
and infant birth outcomes among minority 
Figure 1. Mean ± SE adjusted externalizing BASC-2 score by median 16-week BPA quartile, stratified by 
child sex. Data are adjusted for maternal age (< 25, 25–34, and ≥ 35 years), race (white and nonwhite), 
maternal education (< 12 years, 12 years, > 12 years), household income (< $40,000, $40,000 to < $80,000, 
≥ $80,000), HOME score (< 35, 35 to < 40, and ≥ 40), marital status (married vs. unmarried), and maternal 
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pregnant women in New York City (Wolff 
et al. 2008), and from pregnant women in 
Rotterdam, the Netherlands (Ye et al. 2008).
This study has several limitations. First, the 
children in our sample were 2 years of age at 
the time of behavioral assessment. Patterns of 
behavior are variable during early childhood. 
However, longitudinal analyses of children 
reveal that inattentive/hyperactive behaviors 
tend to be stable over childhood, whereas 
aggressive behaviors decrease (Jester et al. 
2005; Nagin and Tremblay 2001; Tremblay 
et al. 2004). Second, unmeasured confound-
ing may be responsible for some or all of our 
observed associations. Mink et al. (2004) have 
shown that unmeasured confounding can be 
responsible for much of the observed asso-
ciation between environmental neurotoxicants 
and neurobehavioral function. Although we 
included many of the same confounders used 
in studies of other neurotoxicants, it is possible 
that we did not adequately assess parental psy-
chopathology (e.g., parental attention deficit/
hyperactivity disorder). Third, there is evidence 
that prenatal BPA exposure disrupts normal 
mother–child interactions in rodent models 
(Palanza et al. 2008). Female mice exposed to 
BPA spend less time in their nest and nurs-
ing their offspring and more time grooming 
and resting alone. Therefore, associations 
between childhood behavior and prenatal BPA 
exposure may be mediated through maternal 
behavior toward the child. Finally, maternal 
BPA measurements taken at 26 weeks and 
birth may be influenced by the glucose toler-
ance test and birthing process, respectively. 
However, this is unlikely because creatinine-
adjusted BPA concentration distributions were 
almost identical at each time point. We would 
have expected BPA concentrations to be higher 
at birth because women would be more likely 
to be exposed to BPA containing plastics, such 
as intravenous tubing, in the hospital setting 
(Calafat et al. 2009). The lack of a difference 
could be attributable to increased plasma vol-
ume from intravenous fluids, hospital diet or 
fasting near delivery, metabolic changes from 
the birthing process, hospital policies that limit 
BPA-containing plastics, or a combination of 
all of these factors.
Exposure misspecification may be respon-
sible for our observed results. This could bias 
our results toward or away from the null, 
depending on the nature of the misspecifi-
cation and characterization of the expo-
sure (continuous vs. categorical). BPA has 
a short half-life in biological tissues (Volkel 
et al. 2002), although a recent analysis of the 
2003–2004 National Health and Nutrition 
Examination Survey suggests that BPA may 
have a longer than expected half-life (Stahlhut 
et al. 2009). Urinary BPA concentrations 
have a moderate degree of intraindividual 
variability, making it difficult to accurately 
characterize exposure from a single measure-
ment. The lack of prior literature on the appro-
priate specification of BPA exposure during 
pregnancy makes it difficult to determine if a 
single measurement or summary measurement 
of BPA concentration more accurately quanti-
fies exposure. Because women did not have 
repeated urine measurements around 16 weeks 
of gestation, we assumed that timing of the 
16-week urine measurement was random. The 
results of these analyses should be interpreted 
cautiously because this assumption may not 
be true. As recommended previously by Wolff 
et al. (2008), additional research into charac-
terizing BPA exposure is necessary. An addi-
tional source of exposure misspecification may 
have arisen from BPA degradation in sam-
ples that were stored for > 3 years. However, 
prior work indicates that storing urine sam-
ples at subfreezing temperatures for as long as 
30 months does not result in substantial loss 
of BPA (Calafat et al. 2009). 
Another limitation is that we were not 
able to examine whether postnatal BPA expo-
sure was associated with childhood behavior. 
We are planning to examine this association 
in future studies of this cohort.
Selection bias is another potential limita-
tion of our study because women were required 
to be living in pre-1978 housing. It is pos-
sible that children living in older housing stock 
come from lower socioeconomic status, mak-
ing them more likely to have behavior prob-
lems. However, this is unlikely because families 
in our sample have higher levels of education 
and income than the general population.
Finally, there were two statistical limita-
tions to this study. First, it could be argued 
that our observed associations are spurious 
because of the large number of associations 
we examined. However, multiple comparison 
arguments assume that randomness underlies 
the variability of all the observed associations 
(Rothman 1990; Savitz and Olshan 1995). 
It is unlikely that our results are attributable 
to random variation because we observed a 
consistent association between prenatal uri-
nary BPA concentrations and externalizing 
behaviors in females that became stronger 
in measurements taken earlier in pregnancy. 
Second, our power to detect associations 
between maternal BPA exposure and child-
hood behavior was diminished in our analyses 
examining sex- and time-specific associations, 
resulting in imprecise estimates.
This study has several strengths. First, we 
had three urinary BPA measurements in the 
latter two-thirds of pregnancy to estimate ges-
tational exposure. This allowed us to examine 
whether some periods of gestation are sensi-
tive to BPA exposure. Second, we used a valid 
and reliable measure of adaptive and prob-
lem behaviors in children (Kamphaus et al. 
1999). Finally, we are continuing to follow 
these children through 5 years of age, which 
will allow us to examine whether our observed 
associations persist throughout early childhood.
Mean prenatal BPA concentrations were 
not associated with childhood behavior. 
However, we did observe a positive association 
between these concentrations and external-
izing behaviors among females. Early second-
trimester maternal urinary BPA concentrations 
were positively associated with externalizing 
behaviors and global behavior scores among 
all children, but especially among 2-year-
old female children. Our results suggest that 
BPA concentrations in samples taken earlier 
in pregnancy may be more strongly associ-
ated with externalizing scores than those in 
later samples. The reported associations and 
interactions between child sex and timing of 
BPA exposure should be viewed cautiously 
because these results could be biased by expo-
sure misspecification or residual confounding. 
Future research should aim to develop meth-
ods to accurately characterize BPA exposure, 
especially during the first trimester of preg-
nancy; to validate the associations observed 
in this cohort; and to examine the association 
between pre- and postnatal BPA exposure and 
behavior in later childhood.
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